Uehara H - Search Results

1

Insulin receptor expression to predict resistance to axitinib and elucidation of the underlying molecular mechanism in metastatic renal cell carcinoma.

Takahashi M, Daizumoto K, Fukawa T, Fukuhara Y, Bando Y, Kowada M, Dondoo TO, Sasaki Y, Tomida R, Ueno Y, Tsuda M, Kusuhara Y, Yamaguchi K, Yamamoto Y, Uehara H, Kanayama H. Takahashi M, et al. Among authors: uehara h. Br J Cancer. 2023 Aug;129(3):521-530. doi: 10.1038/s41416-023-02325-8. Epub 2023 Jun 24. Br J Cancer. 2023. PMID: 37355721

2

Imaging features of a myoepithelial carcinoma of the nasal cavity: A case report and literature review.

Shinya T, Matsushita T, Hiroshima Y, Otomi Y, Kanematsu Y, Bando Y, Uehara H, Kitamura Y, Harada M. Shinya T, et al. Among authors: uehara h. Radiol Case Rep. 2022 Nov 18;18(1):386-391. doi: 10.1016/j.radcr.2022.10.081. eCollection 2023 Jan. Radiol Case Rep. 2022. PMID: 36425390 Free PMC article.

3

Recurrent multiple liver metastases of clear cell renal cell carcinoma with a significant response to sunitinib after nivolumab treatment.

Tada K, Daizumoto K, Takahashi M, Uehara H, Tsuda M, Kusuhara Y, Fukawa T, Yamamoto Y, Yamaguchi K, Kanayama HO. Tada K, et al. Among authors: uehara h. IJU Case Rep. 2022 Oct 18;6(1):41-44. doi: 10.1002/iju5.12545. eCollection 2023 Jan. IJU Case Rep. 2022. PMID: 36605682 Free PMC article.

4

Histological and immunohistochemical analysis of epithelial cells in epidermoid cysts in intrapancreatic accessory spleen.

Sumida S, Ichimura-Shimizu M, Miyakami Y, Kakimoto T, Kobayashi T, Saijo Y, Matsumoto M, Ogawa H, Oya T, Bando Y, Uehara H, Taira S, Shimada M, Tsuneyama K. Sumida S, et al. Among authors: uehara h. J Med Invest. 2023;70(1.2):251-259. doi: 10.2152/jmi.70.251. J Med Invest. 2023. PMID: 37164730 Free article.

5

Squamous cell carcinoma invading peripheral cerebral blood vessels and causing repeated cerebral hemorrhage : A case report.

Koyama H, Nakajima K, Okita S, Taniguchi H, Hagino H, Bando Y, Uehara H, Takagi Y. Koyama H, et al. Among authors: uehara h. J Med Invest. 2023;70(1.2):276-280. doi: 10.2152/jmi.70.276. J Med Invest. 2023. PMID: 37164733 Free article.

6

Long-Term Outcomes of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy (N-1 Study, Phase II Trial) in Patients With Operable Breast Cancer.

Sasa S, Inoue H, Nakagawa M, Toba H, Goto M, Okumura K, Misaki M, Inui T, Yukishige S, Nishisho A, Hino N, Kanematsu M, Bando Y, Uehara H, Tangoku A, Takizawa H. Sasa S, et al. Among authors: uehara h. Clin Breast Cancer. 2024 Feb 22:S1526-8209(24)00052-1. doi: 10.1016/j.clbc.2024.02.014. Online ahead of print. Clin Breast Cancer. 2024. PMID: 38462397

7

Conversion surgery after successful response to chemotherapy (S-1 + oxaliplatin + nivolumab) in a patient with stage IV gastric cancer with peritoneal metastasis (P1, CY1): a case report.

Noma T, Nishi M, Takasu C, Wada Y, Yoshikawa K, Tokunaga T, Nakao T, Kashihara H, Yoshimoto T, Miyakami Y, Atsumi K, Uehara H, Shimada M. Noma T, et al. Among authors: uehara h. Int Cancer Conf J. 2023 Aug 12;13(1):11-16. doi: 10.1007/s13691-023-00628-4. eCollection 2024 Jan. Int Cancer Conf J. 2023. PMID: 38187176

8

AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells.

Morimoto K, Yamada T, Hirai S, Katayama Y, Fukui S, Sawada R, Tachibana Y, Matsui Y, Nakamura R, Ishida M, Kawachi H, Kunimasa K, Sasaki T, Nishida M, Furuya N, Watanabe S, Shiotsu S, Nishioka N, Horinaka M, Sakai T, Uehara H, Yano S, Son BK, Tokuda S, Takayama K. Morimoto K, et al. Among authors: uehara h. Cancer Lett. 2024 Apr 10;587:216692. doi: 10.1016/j.canlet.2024.216692. Epub 2024 Feb 9. Cancer Lett. 2024. PMID: 38342232 Free article.

9

Pleomorphic type undifferentiated gastric sarcoma, report of a case.

Iwakawa Y, Nishi M, Wada Y, Yoshikawa K, Takasu C, Shimada M, Saijo Y, Matsumoto M, Oya T, Uehara H. Iwakawa Y, et al. Among authors: uehara h. Clin J Gastroenterol. 2023 Feb;16(1):20-25. doi: 10.1007/s12328-022-01729-y. Epub 2022 Oct 26. Clin J Gastroenterol. 2023. PMID: 36289170

10

Pulmonary adenocarcinoma in situ with morule - like components: A surgical case report.

Yosida M, Tomita M, Kawakita N, Shimizu T, Yamada R, Takizawa H, Uehara H. Yosida M, et al. Among authors: uehara h. Respir Med Case Rep. 2024 Mar 11;48:102008. doi: 10.1016/j.rmcr.2024.102008. eCollection 2024. Respir Med Case Rep. 2024. PMID: 38524833 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

884 results

Search Page